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To asses the role of  specific ARF family protein members (there are currently 
six known ARFs), siRNA targeted knock-down of  individual genes is being 
investigated, beginning with Arf1p. This gene knock-down will be verified by 
immunoblot and then effects visualized by immunofluorescence. 
Additionally, observations of  the Golgi in the presence of  BFA and 
Tyrphostin will be made to mesaure their effect on the cell and validate 
previous studies. 
Finally, the role of  other viral and host proteins, such as UL31 and US3, will be 
included with the current technique and experimental design.  
Current & Future Work 
Hypothesis 
Acknowledgments Conclusions 
Special thanks go to the members of  the Baines 
laboratory: Joel Baines, Liz Wills, Serena Chang, Kari 
Roberts, and Kui Yang, for their guidance and 
encouragement. This project was part of  the Cornell 
Veterinary Investigator Program, at the Cornell 
College of  Veterinary Medicine, which is led by 
Robert Gilmour, Janna Lamey, and Casey Isham. 
Funding was provided through the NIH Kirschstein-
NRSA Training Program grants.  
HEp-2 cells infected with HSV-1 and treated with 
BFA or Tyrphostin AG 1478 display an accumulation 
of  UL34 in a punctate pattern throughout the 
nucleoplasm. Untreated infected cells show a smooth 
distribution of  UL34 around the nuclear membrane.  
BFA and Tyrphostin AG 1478 cause a mislocalization 
of  HSV-1 pUL34 in cells infected with HSV-1. 
Further study is warranted. 
Abstract 
Background 
Herpes simplex virus type-1 (HSV-1) buds from the nucleus into the inner 
nuclear membrane (INM), where it forms enveloped capsids in the perinuclear 
space. Viral protein UL34 localizes at the INM, where it recruits and co-
localizes other viral and cellular proteins and is required for viral budding at 
the INM. Brefeldin A (BFA) blocks viral egress through an unknown 
mechanism. It is known that BFA inhibits ADP ribosylation factor (ARF) 
family proteins, which suggests that these proteins may be involved in viral 
egress. To explore this function, we treated HSV-infected cells with BFA and 
observed pUL34 localization in the nucleus by immunofluorescence and 
confocal microscopy. Preliminary results show that infected cells treated with 
BFA or Tyrphostin AG 1478 display a mislocalization of  pUL34 at the INM 
uncharacteristic of  the smooth distribution of  the protein in infected cells that 
were not treated with BFA. Future aspects of  this project will focus on specific 
targets of  BFA, such as Arf1p. This study is relevant because there are UL34 
homologues in all herpesvirus family members and there are no known 
homologues in cellular genes. It is, therefore, an obvious potential target for 
pharmaceutical intervention. 
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The UL34 protein of  HSV-1 requires ADP-ribosylation factor (Arf) proteins for proper viral egress from the nucleus. 
Data & Results 
Viral stock of  HSV-1(F) strain was grown in Vero cells. HEp-2 cells were 
plated at 75% confluency on glass coverslips in 6-well plates with 2 coverslips 
per well. Cells were infected at an multiplicity of  infection (moi) of  10 and 
incubated for 14 hours. Brefeldin and Tyrphostin treatment was performed 3 
hours post-infection (hpi) at 5µM and 14µM, respectively. Cell were fixed in 
-20ºC methanol. Autofluorescence was quenched with 50 mM NH4Cl. Two 
blocking steps were performed (10% human/10% goat serum in PBS, 10% 
BlokHen in PBS). FITC green marker (1:400 anti-chicken) was tagged to α-
UL34. Texas Red red marker (1:100 anti-mouse) was tagged to α-Lamin A/C. 
Fluorescence was visualized with an Olympus IX70 confocal microscope. 
Guanine Nucleotide  
Exchange Factor Inhibitors 
Brefeldin A:  
•  fungal lactone antibiotic 
•  known effects: inhibits protein transport 
from ER to Golgi  
•  known effects: induces retrograde transport 
from Golgi to ER 
•  known effects: blocks nuclear egress of  
HSV-1 
•  BFA targets a GTPase called Arf1p (also 
known as a guanine nucleotide exchange 
factor protein) 
•  Arf1p is involved in recruitment of  coat 
proteins to intracellular membranes for 
vesicular transport 
Tyrphostin AG 1478: 
•  abbreviation of  tyrosine phosphorylation 
inhibitor (a.k.a. TKIs) 
•  synthetic ligand of  the epidermal growth 
factor receptor family  
• more discriminating in inhibition process 
than BFA (higher specificity of  study) 
Figures: 
•  Experimental treatment is presented 
adjacent to controls for each sample.  
•  Confocal microscopy settings were adjusted 
to eliminate non-specific background    
(based on controls using only 2º antibody). 
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The herpesviridae family includes numerous viruses that infect both animals 
and humans. There are many common features across the members. They all 
have dsDNA (approximately 100 Mda) with an RNA transcription step in the 
nucleus. They share an icosahedral capsid structure and a  lipid bilyaer 
envelope. Clinical features in humans are typically oral ulcers or vesicular 
lesions of  specific epithelial cells and nerual ganglion. Infection persists in 
latent and lytic periods after primary infection clears. 
HSV-1 Egress Pathway: 
HSV viral protein UL34 is required for HSV egress from the nucleus (all 
sequenced herpesviruses have a UL34 gene homologue). pUL34 is made in the 
ER and then recruited to the inner nuclear membrane (INM). It co-localizes 
with other viral and cellular proteins related to envelopment. Enveloped 
capsids bud through the INM into the perinuclear space. INM enclosed 
capsids fuse with the ONM for de-envelopment. Virion then moves from ER 
to Golgi network and exocytoses from the cell. 
